• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.87% Nasdaq Up0.34%

    Galectin Therapeutics, Inc. (GALT)

    -NasdaqCM
    3.55 Down 0.09(2.47%) 4:00PM EST
    |After Hours : 3.55 0.00 (0.00%) 4:35PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development5,688  4,527  3,552  
    Selling General and Administrative6,416  5,372  6,857  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (12,104) (9,899) (10,409)
    Income from Continuing Operations
    Total Other Income/Expenses Net16  224  (506)
    Earnings Before Interest And Taxes(12,088)(9,675)(10,915)
    Interest Expense -   -   -  
    Income Before Tax(12,088)(9,675)(10,915)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(12,088)(9,675)(10,915)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (12,088) (9,675) (10,915)
    Preferred Stock And Other Adjustments(9,859)(1,206)(1,798)
    Net Income Applicable To Common Shares (21,947) (10,881) (12,713)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.